TrianglePSMA-guided Salvage Radiation (NCT07234981)
PSMA-guided Salvage Radiation trial for Prostate Cancer (NCT07234981). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for men aged thirty or older with rising or persistent PSA after prostate removal and a targetable recurrence on PSMA imaging or MRI. Distant spread, including pelvic bone disease, excludes participation.
The idea: use imaging to guide salvage radiation. Pelvic treatment comes first, followed by a boost to identified disease. Everyone receives hormone suppression for six to twenty-four months. Recurrence biopsy is optional. Researchers test whether this approach reduces early side effects while maintaining cancer control.
This phase 2 study plans 54 patients. Michael Baine leads Nebraska's recruiting Omaha site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.